China is now a proven biotech powerhouse. So you can keep track, TriaI-Intel can auto-track the clinical progress of your competing clinical-stage China biotechs using TrialWire.AI proprietary AI-analysis tools. Data is pulled from key trial registries, the biotech media, news announcements, and corporate websites. Unlimited searches and tracking, real-time alerts, one dashboard.
$200 / month · unlimited tracked competitors · dashboard & alerts

tracked.competitors / china
Akeso Inc.
Zhongshan · Bispecific Antibody
14
trials
Innovent Biologics
Suzhou · mAb, ADC, GLP-1
19
trials
Junshi Biosciences
Shanghai · Monoclonal Antibody
11
trials
Legend Biotech
Nanjing · CAR-T
8
trials
BeiGene
Beijing · Small Molecule, mAb, ADC
27
trials
last alert
Akeso · ivonescimab Phase 3 expanded to 690 pts — 2h ago
"One-third of the new drugs licensed by large US pharmaceutical companies are from China. A recent analysis shows that China now has gained parity with the US in drug development."
— Science, 2026
JUST A FEW OF THE SYNCED SOURCES
ChiCTRBioSpectrum AsiaANZCTREndpoints NewsFierce BiotechChina BiotechnologyPharmaTimes ChinaPlatform
Unified queries across ClinicalTrials.gov, ChiCTR and ANZCTR — with sponsor, phase, indication and site-level detail.
Pin a company once. We re-scan every 6h, diff against the last snapshot, and surface what's new.
Endpoints, Fierce Biotech, BioCentury, PharmaTimes China and Yicai Global — filtered to your watchlist.
Get an email the moment a tracked competitor opens a new site, shifts a primary completion date or hits the press.
See exactly where trials are being run — country, city and investigator counts mapped at a glance.
Magic-link sign-in, SOC2-ready hosting, audit trail of every alert delivered.
Example dashboard
A snapshot of the demo dashboard you'll get on day one — Akeso, Innovent, Junshi, Legend and BeiGene, all wired to live registry data.
Akeso Inc.
NCT06532145 · ClinicalTrials.gov
Innovent Biologics
ChiCTR2500098123 · ChiCTR
Junshi Biosciences
NCT05891234 · ClinicalTrials.gov
Legend Biotech / J&J
NCT05985721 · ClinicalTrials.gov
BeiGene
NCT06112099 · ClinicalTrials.gov
Data sources
ClinicalTrials.gov
Global
ChiCTR
China
ANZCTR
Australia / NZ
WHO ICTRP
Global
EU CTIS / EudraCT
Europe
ISRCTN
Global
jRCT
Japan
FDA — Drugs@FDA
USA
FDA — openFDA
USA
FDA — Orange Book
USA
EMA
Europe
MHRA
UK
PubMed / MEDLINE
Global
GRID / ROR
Global
NPI Registry
USA
CMS Open Payments
USA
CDC WONDER
USA
SEER
USA
GBD / IHME
Global
Eurostat
Europe
WHO GHO
Global
US Census / ACS
USA
County Health Rankings
USA
BIO / Informa Phase-Transition Benchmarks
Global
TransCelerate Metrics
Global
SDOH Datasets
Global
Media intelligence
TriaI-Intel monitors the biotech press, finance wires and local news that competitors surface in first — so you see the story before it becomes consensus. Media outlets include:
Endpoints News
USA
Fierce Biotech
USA
Fierce Pharma
USA
STAT News
USA
BioPharma Dive
USA
China Biotechnology
China
BioSpectrum Asia
Asia-Pacific
PharmaTimes China
China
Yicai Global
China
Sina Finance
China
21st Century Business Herald
China
Caixin Global
China
Plus 338+ additional outlets across English and Mandarin-language press.
Pricing
Professional
Billed monthly. Cancel anytime.
STRIPE SECURE CHECKOUT · CANCEL ANYTIME
FAQ
ClinicalTrials.gov is polled live; ChiCTR and ANZCTR snapshots refresh every 6 hours. You get an email the moment a tracked competitor changes.
Sign-in is a magic link to your work email. Billing happens through Stripe ($200/month).
Yes — EU CTIS, Japan jRCT, India CTRI and KCT are on the roadmap. Vote in-app and we'll prioritise.